Inve India ▾

Narayana Hrudayalaya share price & results

Narayana Hrudayalaya Ltd.· Healthcare

Results to
Jun 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

Multi-specialty hospital group operating owned/operated hospitals across India, the UK and Cayman Islands

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue2,684 ₹ crore+78.1% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin17.0 %−5.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit207 ₹ crore+5.1% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity21.12 %−3.7 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin9.54 %+11.2 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)59.62 %+31.9 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

1 of 4 judged targets kept · 10 open · verdicts reflect calls analysed to Q1 FY27.

Narayana Hrudayalaya Ltd. management guidance track record on Inve: 14 targets tracked across analysed earnings calls (1 achieved, 3 missed, 10 open).

TargetOriginal wordingSaidLatest callVerdict
Cayman Business Revenue Base$45 million will now be the new base for Cayman business going forward
Call transcript, Q4 FY25 · 27 May 2025
Q4 FY25Q1 FY27:Cayman hospital business continues to grow, with 6% YoY growth in USD terms, reinforcing the new revenue base.
Call transcript, Q1 FY27 · 3 Aug 2026
Achieved
Cayman Integrated Care BreakevenBreakeven to slightly positive, hopefully by the end of the year or 1st Quarter next year (FY27)
Call transcript, Q1 FY26 · 4 Aug 2025
Q1 FY26Q1 FY27:While losses in the Cayman insurance business reduced sequentially to USD 3.7 million, the original breakeven target for Q1 FY27 was not met.
Call transcript, Q1 FY27 · 3 Aug 2026
Missed
Birmingham Centre BreakevenUpdate in a quarter or two once we get a better sense
Call transcript, Q2 FY26 · 3 Nov 2025
Q2 FY26Q1 FY27:Overall UK business performance deteriorated in Q1 FY27 due to operational issues, making the breakeven of the Birmingham unit even more challenging. No specific update provided.
Call transcript, Q1 FY27 · 3 Aug 2026
At Risk

Source: Inve Guidance Tracker for Narayana Hrudayalaya Ltd. · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

3 of Narayana Hrudayalaya Ltd.'s 14 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 11 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹1,713.2 +3.06% · +₹50.9

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −1.3% 1Y

₹1.6k₹1.7k₹1.8k₹1.9k₹2.0k₹2.1kOct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 3 Nov 2025Q3 FY26 — 17 Feb 2026Q4 FY26 — 26 May 2026Q1 FY27 — 3 Aug 2026

1Y: ₹1,734.9 on 24 Oct 2025 → ₹1,713.2. High ₹2,080.3 (30 Jul 2026), low ₹1,605.3 (30 Mar 2026).

Previous close
₹1,662.3
Market cap
₹35.0k Cr
52-week range
₹1,605.3 – ₹2,080.3
One year
−2.06%
Price to earnings (TTM to Jun 2026)
40.62×
Return on equity (TTM to Jun 2026)
21.12%

Overview

Symbol
NSE:NH
Exchange
NSE
Currency
INR

What Narayana Hrudayalaya Ltd. does

Based on the company's own presentations, annual report and earnings calls.

Narayana Hrudayalaya Limited (Narayana Health) is a multi-specialty healthcare provider built around high-complexity cardiac, cancer, renal and neuro sciences care, operating a network of owned and operated hospitals, heart centres, clinics and dialysis centres across India, plus hospital, surgical, diagnostic and ophthalmology centres in the United Kingdom and two "Health City" hospital facilities in the Cayman Islands. It earns from inpatient and outpatient treatment of walk-in, insured, government-scheme and international patients across its hospital network, and also runs an integrated-care arm combining clinics with a health-insurance business, Narayana Health Insurance Limited. The group has built proprietary digital health platforms — Athma (a digital care backbone) and Medha (an AI clinical-support platform) — used across its hospitals.

Segments

  • India Hospitals and Heart Centres
  • India Clinics and Dialysis Centres
  • United Kingdom operations
  • Cayman Islands operations
  • Narayana Health Integrated Care (NHIC)
Healthcare facilities (Group-wide)
55
Total capacity beds (Group-wide)
5,945
India hospitals & heart centres
20 facilities, 5,451 operational beds
India clinics & dialysis centres
20 facilities
United Kingdom facilities
13 hospitals/surgical/diagnostic/ophthalmology centres, 330 beds
Cayman Islands facilities (Health City)
2 facilities, 164 beds
Headquarters Bangalore, Karnataka, IndiaEmployees 20,750 (2026-04-01) Company website

How the price took the results

close before → close after

Q1 FY27
−5.4%
3 Aug
Q4 FY26
−2.5%
26 May
Q3 FY26
−0.4%
17 Feb
Q2 FY26
+1.6%
3 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Narayana Hrudayalaya Ltd.

Free account: one company. Everything above stays public.

Write why you follow Narayana Hrudayalaya Ltd. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds